iShares U.S. Pharmaceuticals ETF (IHE)

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge

IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?

Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It

Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike

GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

Trump to announce discount drug pricing expansion, White House official says

IHE: Healthcare Dashboard For May

The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

Could pressure to make money faster kill the next lifesaving pill?

What Johnson & Johnson Earnings Signal for Healthcare ETFs